Globus Research Development from 2010 to 2026
| GMED Stock | USD 89.61 1.52 1.73% |
Research Development | First Reported 2010-12-31 | Previous Quarter 40 M | Current Value 38.1 M | Quarterly Volatility 12.5 M |
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 306.7 M, Interest Expense of 7.2 M or Total Revenue of 3 B, as well as many indicators such as Price To Sales Ratio of 4.13, Dividend Yield of 0.0 or PTB Ratio of 3.89. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
Globus | Research Development | Build AI portfolio with Globus Stock |
Analyzing Globus Medical's Research Development over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Research Development has evolved provides context for assessing Globus Medical's current valuation and future prospects.
Latest Globus Medical's Research Development Growth Pattern
Below is the plot of the Research Development of Globus Medical over the last few years. It is Globus Medical's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Globus Medical's overall financial position and show how it may be relating to other accounts over time.
| Research Development | 10 Years Trend |
|
Research Development |
| Timeline |
Globus Research Development Regression Statistics
| Arithmetic Mean | 76,396,062 | |
| Geometric Mean | 58,811,004 | |
| Coefficient Of Variation | 76.63 | |
| Mean Deviation | 46,741,492 | |
| Median | 55,496,000 | |
| Standard Deviation | 58,540,181 | |
| Sample Variance | 3427T | |
| Range | 177.2M | |
| R-Value | 0.91 | |
| Mean Square Error | 607.1T | |
| R-Squared | 0.83 | |
| Slope | 10,586,278 | |
| Total Sum of Squares | 54831.2T |
Globus Research Development History
About Globus Medical Financial Statements
Globus Medical stakeholders use historical fundamental indicators, such as Globus Medical's Research Development, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Globus Medical's assets and liabilities are reflected in the revenues and expenses on Globus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Research Development | 188.3 M | 197.7 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:Check out the analysis of Globus Medical Correlation against competitors. For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Will Health Care Equipment & Supplies sector continue expanding? Could Globus diversify its offerings? Factors like these will boost the valuation of Globus Medical. Market participants price Globus higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Globus Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.316 | Earnings Share 3.09 | Revenue Per Share | Quarterly Revenue Growth 0.229 | Return On Assets |
Investors evaluate Globus Medical using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Globus Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Globus Medical's market price to deviate significantly from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Conversely, Globus Medical's market price signifies the transaction level at which participants voluntarily complete trades.